Home Cart 0 Sign in  

[ CAS No. 93267-04-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 93267-04-0
Chemical Structure| 93267-04-0
Structure of 93267-04-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 93267-04-0 ]

Related Doc. of [ 93267-04-0 ]

Alternatived Products of [ 93267-04-0 ]

Product Details of [ 93267-04-0 ]

CAS No. :93267-04-0 MDL No. :MFCD00216579
Formula : C9H16INO4 Boiling Point : -
Linear Structure Formula :- InChI Key :UGZBFCCHLUWCQI-LURJTMIESA-N
M.W : 329.13 Pubchem ID :10903591
Synonyms :
Methyl (R)-2-((tert-butoxycarbonyl)amino)-3-iodopropanoate
Chemical Name :Boc-β-iodo-Ala-OMe

Calculated chemistry of [ 93267-04-0 ]

Physicochemical Properties

Num. heavy atoms : 15
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.78
Num. rotatable bonds : 7
Num. H-bond acceptors : 4.0
Num. H-bond donors : 1.0
Molar Refractivity : 64.14
TPSA : 64.63 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.29 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.6
Log Po/w (XLOGP3) : 1.43
Log Po/w (WLOGP) : 1.49
Log Po/w (MLOGP) : 1.42
Log Po/w (SILICOS-IT) : 1.3
Consensus Log Po/w : 1.65

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.32
Solubility : 1.58 mg/ml ; 0.00479 mol/l
Class : Soluble
Log S (Ali) : -2.39
Solubility : 1.33 mg/ml ; 0.00405 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.29
Solubility : 1.71 mg/ml ; 0.00519 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 3.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 3.09

Safety of [ 93267-04-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 93267-04-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 93267-04-0 ]
  • Downstream synthetic route of [ 93267-04-0 ]

[ 93267-04-0 ] Synthesis Path-Upstream   1~6

  • 1
  • [ 2766-43-0 ]
  • [ 93267-04-0 ]
YieldReaction ConditionsOperation in experiment
68% at 0 - 20℃; for 1.5 h; A mixture of triphenylphosphine (131 g, 0.500 mol) and imidazole (34 g, 0.50 mol) in DCM (600 mL) was cooled to 0 °C and iodide (127 g, 0.50 mol) was added in small portions over 0.5 h. The cooling bath was removed and the mixture was stirred for 0.5 h. After the mixture was re-cooled to 0 °C, a solution of (5)-methyl 2-((tert- butoxycarbonyl)amino)-3-hydroxypropanoate (73 g, 0.33 mol) in DCM (300 mL) was added dropwise. After the addition, the cooling bath was removed and the mixture was allowed to warm to ambient temperature and stirred for 1.5 h. The mixture was filtered and the filtrate was concentrated to remove most of the solvent. MTBE (400 mL) was added to the residue and the mixture was filtered to remove triphenylphosphine oxide. The filtrate was concentrated and the residue was purified by flash column chromatography on silica gel to afford (i?)-methyl 2-((tert-butoxycarbonyl)amino)-3-iodopropanoate (74.0 g, 68percent yield) as a colorless solid.
67%
Stage #1: With methyltriphenoxyphosphonium iodide In N,N-dimethyl-formamide at 0℃; for 0.5 h;
Stage #2: With sodium hydrogencarbonate In water; N,N-dimethyl-formamide for 0.25 h;
Triphenylphosphite methiodide (Fieser and Fieser, Reagents for Organic Synthesis, Vol. 4, p557; 34Og, 753 mmol, 1.4 equiv.) was added in one portion to a solution of (S)-2- rert-butyloxycarbonylamino-3-hydroxypropionic acid methyl ester (118g, 538 mmol) in dry N,N-dimethylformamide (1.1 L) at 0°C. After 30 minutes at O0C solid sodium bicarbonate (27Og) was added followed by water (1. IL). The resulting mixture was stirred vigorously for 15 minutes and then extracted with 1:1 diethylether/hexanes (3 x 80OmL). The combined organic extracts were washed with 0.5M sodium hydroxide (5 x IL) and brine (2 x IL), dried over magnesium sulfate, filtered, and the filtrate concentrated under reduced pressure. The resulting orange oil was loaded onto a SiO2 plug (2" x 7") and eluted with 5percent EtOAc/hexanes to afford (R)-methyl 2-(tert-butoxycarbonylamino)-3-iodopropanoate as a pinkish oil, which solidified (118.5g, 67percent) 1H NMR (CDC13; 400MHz): δppm 5.32 (m, IH), 4.51 (m, IH), 3.81 (s, 3H), 3.58 (m, 2H), 1.45 (s, 9H).
65% With 1H-imidazole; iodine; triphenylphosphine In dichloromethane at 0 - 20℃; for 3 h; Inert atmosphere Triphenylphosphine (66.0 g, 0.250 mol) and imidazole (17.1 g, 0.250 mol) were dissolved in methylene chloride (900 ml). After cooling to 0° C., iodine (64.0 g, 0.250 mol) was added thereto, and the temperature was gradually raised from 0° C. to room temperature in the presence of nitrogen gas, followed by stirring for 10 minutes. After cooling to 0° C., a methylene chloride solution (100 of methyl N-(tert-butoxycarbonyl)-L-serinate (45.0 g, 0.200 mol) was slowly added dropwise over one hour, followed by stirring at room temperature for 2 hours. After the reaction solution was filtered, the filtrate was concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography (petroleum ether/ethyl acetate=1:1 to 1:2) to obtain the title compound (43.8 g, 65percent). [0585] 1H NMR (CDCl3, 400 MHz): δ 5.36-5.34 (m, 1H), 4.53-4.51 (m, 1H), 3.80 (s, 3H), 3.61-3.53 (m, 2H), 1.46 (s, 9H)
Reference: [1] Journal of Organic Chemistry, 2009, vol. 74, # 17, p. 6792 - 6796
[2] Organic Letters, 2003, vol. 5, # 24, p. 4599 - 4602
[3] Organic Letters, 2011, vol. 13, # 10, p. 2614 - 2617
[4] Tetrahedron, 2017, vol. 73, # 42, p. 6085 - 6091
[5] Tetrahedron Letters, 2007, vol. 48, # 16, p. 2857 - 2859
[6] ACS Medicinal Chemistry Letters, 2015, vol. 6, # 12, p. 1199 - 1203
[7] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 15, p. 4427 - 4431
[8] Patent: WO2014/152127, 2014, A1, . Location in patent: Paragraph 00319; 00322
[9] Patent: WO2010/56877, 2010, A2, . Location in patent: Page/Page column 53
[10] Patent: US2015/51395, 2015, A1, . Location in patent: Paragraph 0584-0585
[11] Journal of the Chemical Society, Dalton Transactions, 2001, # 18, p. 2655 - 2662
[12] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 1, p. 191 - 195
[13] Phosphorus, Sulfur and Silicon and the Related Elements, 1998, vol. 136, p. 611 - 616
[14] Journal of the Chemical Society - Perkin Transactions 1, 1997, # 16, p. 2443 - 2447
[15] Synlett, 1997, vol. 1997, # 2, p. 169 - 170
[16] Tetrahedron Letters, 1994, vol. 35, # 4, p. 551 - 554
[17] Tetrahedron, 1985, vol. 41, # 10, p. 1833 - 1845
[18] Journal of the American Chemical Society, 2014, vol. 136, # 35, p. 12469 - 12478
[19] RSC Advances, 2015, vol. 5, # 64, p. 51807 - 51811
[20] Patent: US2016/185821, 2016, A1, . Location in patent: Paragraph 0383; 0384; 0385
[21] Arkivoc, 2016, vol. 2017, # 2, p. 260 - 271
[22] Organic Syntheses, 2005, vol. 81, p. 77 - 88
[23] Patent: WO2007/144379, 2007, A1, . Location in patent: Page/Page column 34
  • 2
  • [ 56926-94-4 ]
  • [ 93267-04-0 ]
Reference: [1] Journal of the Chemical Society - Perkin Transactions 1, 1997, # 16, p. 2443 - 2447
[2] Organic Syntheses, 2005, vol. 81, p. 77 - 88
[3] Tetrahedron, 1985, vol. 41, # 10, p. 1833 - 1845
[4] Tetrahedron Letters, 1984, vol. 25, # 26, p. 2759 - 2762
[5] Tetrahedron Letters, 1994, vol. 35, # 4, p. 551 - 554
[6] Phosphorus, Sulfur and Silicon and the Related Elements, 1998, vol. 136, p. 611 - 616
  • 3
  • [ 2766-43-0 ]
  • [ 55477-80-0 ]
  • [ 93267-04-0 ]
Reference: [1] Organic Syntheses, 2016, vol. 92, p. 103 - 116
[2] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 15, p. 4427 - 4431
  • 4
  • [ 24424-99-5 ]
  • [ 93267-04-0 ]
Reference: [1] Organic Letters, 2003, vol. 5, # 24, p. 4599 - 4602
[2] Tetrahedron, 1985, vol. 41, # 10, p. 1833 - 1845
[3] Patent: WO2014/152127, 2014, A1,
[4] Arkivoc, 2016, vol. 2017, # 2, p. 260 - 271
  • 5
  • [ 3262-72-4 ]
  • [ 93267-04-0 ]
Reference: [1] Tetrahedron Letters, 2007, vol. 48, # 16, p. 2857 - 2859
[2] Arkivoc, 2016, vol. 2017, # 2, p. 260 - 271
  • 6
  • [ 187035-34-3 ]
  • [ 93267-04-0 ]
Reference: [1] Synlett, 1997, vol. 1997, # 2, p. 169 - 170
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 93267-04-0 ]

Amino Acid Derivatives

Chemical Structure| 28875-17-4

[ 28875-17-4 ]

Boc-Ala-OMe

Similarity: 0.84

Chemical Structure| 91103-47-8

[ 91103-47-8 ]

Boc-D-Ala-OMe

Similarity: 0.84

Chemical Structure| 69942-12-7

[ 69942-12-7 ]

Methyl 2-((tert-butoxycarbonyl)amino)-3-hydroxypropanoate

Similarity: 0.81

Chemical Structure| 2766-43-0

[ 2766-43-0 ]

Boc-Ser-OMe

Similarity: 0.81

Chemical Structure| 95715-85-8

[ 95715-85-8 ]

Boc-D-Ser-OMe

Similarity: 0.81